Select Date
Select Date
2026-10 10
Tat-beclin 1 Tatbeclin 1 from Selleck Target BECN1 for Ischemic Stroke Neuroprotection
Tat-beclin 1 Tatbeclin 1 from Selleck Target BECN1 for Ischemic Stroke Neuroprotection
PKR-IN-C16 PKR inhibitor modulating C16 transition metal boride electronic structure and magnetic anisotropy
PKR-IN-C16 PKR inhibitor modulating C16 transition metal boride electronic structure and magnetic anisotropy
Firsocostat targeted inhibition of acetyl-CoA carboxylase restores Leydig cell steroidogenesis in metabolic dysfunction
Firsocostat targeted inhibition of acetyl-CoA carboxylase restores Leydig cell steroidogenesis in metabolic dysfunction
Vorapaxar and PAR-1 Inhibition for Long-Term Prevention of Atherothrombotic Events
Vorapaxar and PAR-1 Inhibition for Long-Term Prevention of Atherothrombotic Events
Tiplaxtinin PAI-1 inhibitor Tiplaxtinin (PAI-039) regulates CHRNA1 expression in cholinergic sweat gland secretion
Tiplaxtinin PAI-1 inhibitor Tiplaxtinin (PAI-039) regulates CHRNA1 expression in cholinergic sweat gland secretion
Dooku1 Mechanosensitive Cha Antagonism Accelerates Trigeminal Axonal Regeneration Post-Axotomy
Dooku1 Mechanosensitive Cha Antagonism Accelerates Trigeminal Axonal Regeneration Post-Axotomy
NNMTi NNMT inhibitor Disruption of Methylation Dynamics Restores Epigenetic Control in Solid Tumors
NNMTi NNMT inhibitor Disruption of Methylation Dynamics Restores Epigenetic Control in Solid Tumors
BMS-303141 Inhibits ATP Citrate Lyase to Suppress Hepatic Alanine-Driven Gluconeogenesis
BMS-303141 Inhibits ATP Citrate Lyase to Suppress Hepatic Alanine-Driven Gluconeogenesis
BMS-309403 from Selleck inhibits FABP4 to attenuate steatotic liver ischemia-reperfusion injury
BMS-309403 from Selleck inhibits FABP4 to attenuate steatotic liver ischemia-reperfusion injury
WRW4 FPR antagonist attenuates formyl peptide receptor 2 signaling in stem cells
WRW4 FPR antagonist attenuates formyl peptide receptor 2 signaling in stem cells